antrafenine   Click here for help

GtoPdb Ligand ID: 14685

Synonyms: Compound 45 [PMID: 458805] | SL 73-033 | SL73-033 | Stakane®
Approved drug
antrafenine is an approved drug
Compound class: Synthetic organic
Comment: Antrafenine is an old drug that has analgesic and anti-inflammatory properties [3]. More recently (2025) antrafenine was reported to reduce KNa1.1 (KCNT1) channel activity in vitro, and to reduce seizure activity in a Drosophila model of KCNT1-related epilepsy (caused by gain‐of‐function KCNT1 mutations), leading to the hypothesis that suppressing the overactive channels offers a novel therapeutic intervention for this form of genetic epilepsy [4].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 10
Topological polar surface area 57.17
Molecular weight 588.54
XLogP 4.07
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1=CC(=C(C=C1)NC2=CC=NC3=CC(=CC=C23)C(F)(F)F)C(=O)OCCN4CCN(CC4)C5=CC(=CC=C5)C(F)(F)F
Isomeric SMILES C1CN(CCN1CCOC(=O)C2=CC=CC=C2NC3=C4C=CC(=CC4=NC=C3)C(F)(F)F)C5=CC=CC(=C5)C(F)(F)F
InChI InChI=1S/C30H26F6N4O2/c31-29(32,33)20-4-3-5-22(18-20)40-14-12-39(13-15-40)16-17-42-28(41)24-6-1-2-7-25(24)38-26-10-11-37-27-19-21(30(34,35)36)8-9-23(26)27/h1-11,18-19H,12-17H2,(H,37,38)
InChI Key NWGGKKGAFZIVBJ-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Selectivity at ion channels
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
KNa1.1 Hs Channel blocker Antagonist 5.9 pIC50 - 4
⤷ pIC50 5.9 (IC50 1.3x10-6 M) [4]
Description: Using the WT/Y796H KCNT1 construct as a model of the heterozygous KCNT1 pathogenic variant; evaluated in whole‐cell patch clamp experiments